AngioDynamics Says Humana Updates Medicare Advantage Policy To Cover NanoKnife For Eligible Prostate And Liver Cancer Patients, Effective October 1
Share
Why It Matters
Humana insurance will now cover AngioDynamics' NanoKnife cancer treatment starting October first. This means more patients can afford the tool, which could help the company sell more.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.